Nifty
Sensex
:
:
11657.05
38811.39
-80.85 (-0.69%)
-298.82 (-0.76%)

Pharmaceuticals & Drugs

Rating :
50/99

BSE: 532612 | NSE: INDOCO

182.45
-2.50 (-1.35%)
23-May-2019 | 3:31PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  185.70
  •  187.70
  •  181.85
  •  184.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9539
  •  17.40
  •  238.90
  •  148.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,684.51
  • 279.35
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,954.61
  • 0.55%
  • 2.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.68%
  • 0.00%
  • 19.24%
  • FII
  • DII
  • Others
  • 0.03%
  • 12.72%
  • 9.33%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.47
  • 7.37
  • 1.10

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.03
  • 2.21
  • -4.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.74
  • -6.58
  • -20.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.18
  • 36.04
  • 39.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.18
  • 4.15
  • 3.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.77
  • 17.26
  • 16.97

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Net Sales
-
1,041.94
1,074.77
1,008.12
857.32
732.61
630.79
243.43
194.15
Net Sales Growth
-
-3.05%
6.61%
17.59%
17.02%
16.14%
159.13%
25.38%
 
Cost Of Goods Sold
-
347.83
361.27
350.01
300.44
271.98
262.57
104.32
81.04
Gross Profit
-
694.11
713.49
658.12
556.87
460.63
368.22
139.10
113.10
GP Margin
-
66.62%
66.39%
65.28%
64.95%
62.88%
58.37%
57.14%
58.25%
Total Expenditure
-
910.37
920.27
840.17
691.81
614.44
538.15
198.37
154.21
Power & Fuel Cost
-
26.62
23.12
21.72
20.39
18.26
16.37
7.32
4.17
% Of Sales
-
2.55%
2.15%
2.15%
2.38%
2.49%
2.60%
3.01%
2.15%
Employee Cost
-
220.91
216.67
181.87
140.04
129.54
107.87
25.71
20.09
% Of Sales
-
21.20%
20.16%
18.04%
16.33%
17.68%
17.10%
10.56%
10.35%
Manufacturing Exp.
-
101.94
96.38
85.18
52.92
40.58
34.30
14.25
9.22
% Of Sales
-
9.78%
8.97%
8.45%
6.17%
5.54%
5.44%
5.85%
4.75%
General & Admin Exp.
-
110.04
116.40
102.56
90.39
83.49
66.64
25.10
22.56
% Of Sales
-
10.56%
10.83%
10.17%
10.54%
11.40%
10.56%
10.31%
11.62%
Selling & Distn. Exp.
-
70.53
73.22
55.89
51.00
47.83
33.02
15.97
12.76
% Of Sales
-
6.77%
6.81%
5.54%
5.95%
6.53%
5.23%
6.56%
6.57%
Miscellaneous Exp.
-
32.49
33.20
42.94
36.63
22.75
17.38
5.70
4.37
% Of Sales
-
3.12%
3.09%
4.26%
4.27%
3.11%
2.76%
2.34%
2.25%
EBITDA
-
131.57
154.50
167.95
165.51
118.17
92.64
45.06
39.94
EBITDA Margin
-
12.63%
14.38%
16.66%
19.31%
16.13%
14.69%
18.51%
20.57%
Other Income
-
8.05
5.93
4.03
1.71
3.97
1.50
10.02
4.81
Interest
-
23.51
6.21
12.39
10.58
18.92
21.87
5.79
3.75
Depreciation
-
67.71
63.28
60.66
47.09
30.90
23.72
6.32
4.34
PBT
-
48.40
90.94
98.93
109.55
72.32
48.55
42.96
36.65
Tax
-
7.24
13.87
16.99
26.73
14.28
5.79
11.47
11.61
Tax Rate
-
14.96%
15.25%
17.17%
24.40%
19.75%
11.93%
26.70%
31.68%
PAT
-
41.16
77.06
81.94
82.81
57.98
42.72
31.49
25.04
PAT before Minority Interest
-
41.16
77.06
81.94
82.81
58.03
42.76
31.49
25.04
Minority Interest
-
0.00
0.00
0.00
0.00
-0.05
-0.04
0.00
0.00
PAT Margin
-
3.95%
7.17%
8.13%
9.66%
7.91%
6.77%
12.94%
12.90%
PAT Growth
-
-46.59%
-5.96%
-1.05%
42.83%
35.72%
35.66%
25.76%
 
Unadjusted EPS
-
4.47
8.36
8.89
8.99
6.29
4.64
26.64
21.18

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Shareholder's Funds
674.98
651.34
576.52
518.80
457.15
414.17
198.38
175.31
Share Capital
18.43
18.43
18.43
18.43
18.43
18.43
11.82
11.82
Total Reserves
656.55
632.91
558.08
500.37
438.72
395.74
186.56
163.49
Non-Current Liabilities
125.34
147.04
66.28
64.65
69.87
78.22
53.79
59.52
Secured Loans
123.28
132.31
34.24
9.42
7.20
21.41
26.45
30.37
Unsecured Loans
0.00
0.00
3.64
3.44
6.59
5.97
9.81
19.39
Long Term Provisions
23.77
30.91
40.63
15.04
16.36
6.82
0.00
0.00
Current Liabilities
415.69
390.39
302.95
262.12
202.15
199.28
58.53
50.09
Trade Payables
149.55
164.03
131.31
119.86
70.66
68.26
41.06
34.19
Other Current Liabilities
117.99
72.16
57.38
40.97
53.98
51.34
7.40
7.32
Short Term Borrowings
109.93
118.36
87.23
75.38
57.96
64.84
0.00
0.00
Short Term Provisions
38.22
35.84
27.03
25.92
19.54
14.84
10.07
8.58
Total Liabilities
1,216.01
1,188.77
945.75
845.57
729.42
691.87
310.70
284.92
Net Block
488.86
439.89
373.64
339.80
325.43
321.55
138.99
83.28
Gross Block
885.11
769.65
641.95
547.64
481.56
447.06
165.56
103.94
Accumulated Depreciation
396.25
329.75
268.32
207.84
156.13
125.51
26.57
20.65
Non Current Assets
678.73
616.72
481.20
460.22
424.85
416.36
143.54
96.15
Capital Work in Progress
135.56
90.63
54.80
62.71
44.12
37.78
4.55
12.86
Non Current Investment
0.02
0.02
0.02
0.17
0.17
0.12
0.00
0.00
Long Term Loans & Adv.
33.92
66.46
48.15
57.31
54.88
56.59
0.00
0.00
Other Non Current Assets
20.36
19.72
4.60
0.22
0.25
0.31
0.00
0.00
Current Assets
537.29
572.05
464.55
385.36
304.56
275.51
166.28
187.37
Current Investments
0.00
0.00
15.68
0.00
0.00
0.00
6.33
40.07
Inventories
193.38
186.94
166.69
149.12
110.22
93.18
35.60
30.11
Sundry Debtors
207.83
215.68
188.83
155.38
138.13
127.08
83.41
74.07
Cash & Bank
11.90
62.59
12.63
15.40
13.39
13.99
25.20
28.58
Other Current Assets
124.17
17.64
8.66
4.33
42.83
41.25
15.73
14.54
Short Term Loans & Adv.
117.71
89.21
72.06
61.13
38.68
35.29
15.73
14.54
Net Current Assets
121.60
181.66
161.60
123.23
102.41
76.23
107.75
137.28
Total Assets
1,216.02
1,188.77
945.75
845.58
729.41
691.87
310.70
284.92

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Cash From Operating Activity
122.72
88.64
113.34
109.04
98.81
68.69
36.99
6.11
PBT
48.40
90.94
100.58
109.55
72.32
48.55
42.96
36.65
Adjustment
97.67
64.60
76.29
65.21
50.38
47.14
6.77
4.11
Changes in Working Capital
-13.23
-43.25
-36.12
-41.01
-9.16
-18.57
-5.99
-26.02
Cash after chg. in Working capital
132.83
112.29
140.75
133.75
113.53
77.12
43.73
14.74
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-10.12
-23.65
-27.41
-24.71
-14.72
-8.43
-6.74
-8.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-136.01
-170.55
-111.96
-88.41
-40.98
-42.61
-15.75
-89.60
Net Fixed Assets
-160.40
-163.74
-86.39
-84.46
-40.81
-349.01
-29.62
Net Investments
0.21
15.47
-17.65
-0.19
-0.05
11.09
33.74
Others
24.18
-22.28
-7.92
-3.76
-0.12
295.31
-19.87
Cash from Financing Activity
-38.77
131.57
-1.48
-19.92
-58.98
-24.41
-24.61
94.50
Net Cash Inflow / Outflow
-52.06
49.66
-0.11
0.70
-1.15
1.67
-3.38
11.01
Opening Cash & Equivalents
60.06
10.40
10.47
9.77
10.92
9.25
28.58
17.57
Closing Cash & Equivalent
8.00
60.06
10.36
10.47
9.77
10.92
25.20
28.58

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Jun 06
Jun 05
Book Value (Rs.)
73.25
70.68
62.56
56.30
49.61
44.94
22.28
19.62
ROA
3.42%
7.22%
9.15%
10.52%
8.17%
8.53%
10.57%
8.79%
ROE
6.21%
12.55%
14.96%
16.97%
13.32%
13.98%
16.96%
14.40%
ROCE
7.62%
11.80%
16.72%
20.63%
16.84%
18.33%
21.31%
18.06%
Fixed Asset Turnover
1.26
1.55
1.69
1.69
1.61
2.10
2.00
2.08
Receivable days
73.94
67.31
62.31
61.67
64.94
59.83
106.60
125.29
Inventory Days
66.40
58.84
57.17
54.49
49.80
36.61
44.48
50.93
Payable days
58.67
61.79
56.58
52.08
43.51
39.89
77.53
93.34
Cash Conversion Cycle
81.68
64.37
62.91
64.09
71.24
56.55
73.55
82.88
Total Debt/Equity
0.42
0.43
0.24
0.19
0.20
0.29
0.18
0.29
Interest Cover
3.06
15.64
8.98
11.35
4.82
3.22
8.41
10.77

News Update:


  • Indoco Remedies receives UK-MHRA’s nod for new solid dosages facility in Baddi
    8th May 2019, 11:27 AM

    The facility is spread over an area of 18000 sqm, with manufacturing capacity of 4.3 billion tablets and 50 million capsules p.a.

    Read More
  • USFDA retains OAI status for Indoco’s Goa Plant
    24th Apr 2019, 11:20 AM

    The facility was inspected by the USFDA in January 2019

    Read More
  • Indoco Remedies gets USFDA's nod for sterile manufacturing facility
    29th Mar 2019, 15:51 PM

    USFDA has signified that the site has come out of the ‘Warning Letter’ issued to the site in March 2017

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.